VITA Accelerator

DINO: The Future of Early Learning Disorder Detection In today’s educational landscape, learning disorders often go undiagnosed until they become significant barriers to academic success. This late detection leads to higher intervention costs, greater emotional distress for children, and increased strain on teachers and families. DINO is revolutionizing the way we approach early learning disorder identification by leveraging AI, gamification, and data-driven insights to create a scalable, efficient, and engaging solution for schools. Our mission is simple: ensure that every child, regardless of background or geography, has access to early and accurate learning disorder detection. By intervening at the right time, we empower schools, educators, and families to provide the best possible support for students who need it most. A Disruptive Approach to Educational Assessment Traditional methods of identifying learning difficulties are often time-consuming, resource-intensive, and dependent on expert evaluations that may not be readily available. DINO changes this paradigm by offering: AI-powered early detection – Our intelligent algorithms analyze gameplay data to identify potential learning challenges in real time. Gamified assessment – Students engage in fun, interactive activities that collect meaningful cognitive and linguistic data without creating stress or pressure. Minimal teacher intervention – The tool is designed for independent use, allowing educators to focus on classroom instruction while gathering valuable insights. Scalability and cost-efficiency – Unlike traditional assessment methods, DINO can be deployed in multiple schools with minimal logistical constraints. Proven Business Model & Strong Market Validation DINO’s business model has been successfully implemented in Italy, demonstrating strong financial sustainability and market demand. Our approach is based on: A subscription-based pricing model: Schools pay a setup fee (€200 per institution) and an annual fee per student (€10 per child), ensuring affordability while maintaining profitability. High margins and low operational costs: Delivery costs are minimal (€1 per report, totaling €2 per child annually), allowing for flexible pricing adaptation, with an average deal size of €1,350 per school.

HuCare is a healthcare technology company focused on enhancing therapy adherence by facilitating communication between patients and healthcare providers. The company offers a secure platform that includes tools for clinical trial management, patient relationship management, and a COVID-19 patient tracking system. By improving the interaction between patients and the health system, HuCare aims to support general practitioners in maintaining safety and controlling the spread of diseases like COVID-19. Through these innovative solutions, HuCare seeks to address critical gaps in healthcare delivery and improve overall patient outcomes.

InGeno is a provider of genetic-based personalized products focused on skin, hair, and nutrition. The company specializes in diagnostic and therapeutic solutions that utilize DNA analysis to tailor treatments according to individual characteristics. This personalized approach aims to address specific needs effectively, helping users identify underlying issues and develop wellness programs based on their genetic profiles. By leveraging insights from DNA, InGeno seeks to enhance the efficacy of treatments and improve overall customer satisfaction in the realm of personalized healthcare.

Evotion is a health monitoring smart wearable company.

DINO: The Future of Early Learning Disorder Detection In today’s educational landscape, learning disorders often go undiagnosed until they become significant barriers to academic success. This late detection leads to higher intervention costs, greater emotional distress for children, and increased strain on teachers and families. DINO is revolutionizing the way we approach early learning disorder identification by leveraging AI, gamification, and data-driven insights to create a scalable, efficient, and engaging solution for schools. Our mission is simple: ensure that every child, regardless of background or geography, has access to early and accurate learning disorder detection. By intervening at the right time, we empower schools, educators, and families to provide the best possible support for students who need it most. A Disruptive Approach to Educational Assessment Traditional methods of identifying learning difficulties are often time-consuming, resource-intensive, and dependent on expert evaluations that may not be readily available. DINO changes this paradigm by offering: AI-powered early detection – Our intelligent algorithms analyze gameplay data to identify potential learning challenges in real time. Gamified assessment – Students engage in fun, interactive activities that collect meaningful cognitive and linguistic data without creating stress or pressure. Minimal teacher intervention – The tool is designed for independent use, allowing educators to focus on classroom instruction while gathering valuable insights. Scalability and cost-efficiency – Unlike traditional assessment methods, DINO can be deployed in multiple schools with minimal logistical constraints. Proven Business Model & Strong Market Validation DINO’s business model has been successfully implemented in Italy, demonstrating strong financial sustainability and market demand. Our approach is based on: A subscription-based pricing model: Schools pay a setup fee (€200 per institution) and an annual fee per student (€10 per child), ensuring affordability while maintaining profitability. High margins and low operational costs: Delivery costs are minimal (€1 per report, totaling €2 per child annually), allowing for flexible pricing adaptation, with an average deal size of €1,350 per school.

MederiAI uses AI to detect GI anomalies in endoscopy pill footage, cutting review time for doctors and clinics.